---
title: "Protagenic Therapeutics exec chair Garo H. Armen acquires 5,000 common shares for $1,294"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295160382.md"
description: "Garo H. Armen, Executive Chair of Protagenic Therapeutics, acquired 5,000 common shares at $0.26 per share for a total of $1,294. This transaction increased his direct holdings to 31,294 shares."
datetime: "2026-08-07T00:30:17.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295160382.md)
  - [en](https://longbridge.com/en/news/295160382.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295160382.md)
generator: "portal-rs"
---

# Protagenic Therapeutics exec chair Garo H. Armen acquires 5,000 common shares for $1,294

-   Garo H. Armen, executive chair and principal officer of Protagenic Therapeutics, bought 5,000 common shares. \* Purchase price was $0.26 per share. \* Armen’s direct holding rose to 31,294 common shares. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Protagenic Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-036442), on August 06, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [PTIX.US](https://longbridge.com/en/quote/PTIX.US.md)
- [PTGX.US](https://longbridge.com/en/quote/PTGX.US.md)

## Related News & Research

- [Protagenic Therapeutics executive chair Garo H. Armen acquires 20,000 common shares for $13,000](https://longbridge.com/en/news/296815833.md)
- [Protagenic Therapeutics executive chair Garo H. Armen acquires 2,700 common shares for $945](https://longbridge.com/en/news/296498804.md)
- [Mexedia notifies availability of press release](https://longbridge.com/en/news/298011253.md)
- [Renewi backs Dutch taskforce action agenda for fully circular electronics supply chain by 2050](https://longbridge.com/en/news/298002754.md)
- [Bel Fuse director Vincent Vellucci disposes of 393 common shares worth $95,738.73](https://longbridge.com/en/news/298055432.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**